Responsive polymersomes enhance the action of STING-targeting cyclic dinucleotides in cancer therapy.
References
Adams, D. et al. N. Engl. J. Med. 379, 11–21 (2018).
Coelho, T. et al. N. Engl. J. Med. 369, 819–829 (2013).
Shae, D. et al. Nat. Nanotechnol. https://doi.org/10.1038/s41565-018-0342-5 (2019).
Chen, Q., Sun, L. & Chen, Z. J. Nat. Immunol. 17, 1142–1149 (2016).
Ablasser, A. et al. Nature 498, 380–384 (2013).
Corrales, L., McWhirter, S. M., Dubensky, T. W. & Gajewski, T. F. J. Clin. Invest. 126, 2404–2411 (2016).
Woo, S.-R. et al. Immunity 41, 830–842 (2014).
Corrales, L. et al. Cell Rep. 11, 1018–1030 (2015).
Fu, J. et al. Sci. Transl. Med. 7, 283ra52 (2015).
Foote, J. B. et al. Cancer Immunol. Res. 5, 468–479 (2017).
Hanson, M. C. et al. J. Clin. Invest. 125, 2532–2546 (2015).
Koshy, S. T., Cheung, A. S., Gu, L., Graveline, A. R. & Mooney, D. J. Adv. Biosyst. 1, 1600013 (2017).
Manganiello, M. J., Cheng, C., Convertine, A. J., Bryers, J. D. & Stayton, P. S. Biomaterials 33, 2301–2309 (2012).
Author information
Authors and Affiliations
Corresponding authors
Rights and permissions
About this article
Cite this article
Hubbell, J.A., Swartz, M.A. Trojan horses for immunotherapy. Nat. Nanotechnol. 14, 196–197 (2019). https://doi.org/10.1038/s41565-019-0380-7
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41565-019-0380-7
- Springer Nature Limited